USE OF CA-19-9 IN THE EARLY DETECTION OF RECURRENCES IN COLORECTAL-CANCER - COMPARISON WITH CEA

被引：46

作者：

FILELLA, X

MOLINA, R

PIQUE, JM

GARCIAVALDECASAS, JC

GRAU, JJ

NOVELL, F

ASTUDILLO, E

DELACY, A

DANIELS, M

BALLESTA, AM

机构：

[1] HOSP CLIN BARCELONA,DEPT GASTROENTEROL,BARCELONA,SPAIN

[2] HOSP CLIN BARCELONA,DEPT SURG,BARCELONA,SPAIN

[3] HOSP CLIN BARCELONA,DEPT ONCOL,BARCELONA,SPAIN

来源：

TUMOR BIOLOGY | 1994年 / 15卷 / 01期

关键词：

CA; 19-9; CEA; CANCER-ASSOCIATED ANTIGENS; COLORECTAL CANCER; FOLLOW-UP;

D O I：

10.1159/000217867

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The serum levels of CA 19-9 were determined in the follow-up of 370 patients with colorectal cancer and compared with CEA. An increase in CA 19-9 preceded clinical diagnosis of recurrence in 25% of 72 patients. The mean time between the rise in CA 19-9 and clinical diagnosis of relapse was 3.7 months (median 3). Sensitivity of CA 19-9 in the early diagnosis of recurrence was much lower than that obtained for CEA (75%). Only 1 patient had elevated CA 19-9 levels and normal CEA.

引用

页码：1 / 6

页数：6

共 50 条

[31] A RETROSPECTIVE STUDY OF SERIAL CEA DETERMINATIONS IN THE EARLY DETECTION OF RECURRENT COLORECTAL-CANCER
WEDELL, J
EISSEN, PMZ
LUU, TH
FIEDLER, R
VANCALKER, H
KOLDOWSKI, P
SCHLIPKOTER, HW
DISEASES OF THE COLON & RECTUM, 1981, 24 (08) : 618 - 621
[32] EARLY DETECTION OF COLORECTAL-CANCER
不详
SOUTH AFRICAN MEDICAL JOURNAL, 1984, 66 (06): : 201 - 201
[33] CA 19-9 ANTIBODY IN COLORECTAL-CANCER AND SYNCHRONOUS ADENOMATA
AFDHAL, NH
LONG, A
TOBIN, B
ODONOGHUE, DP
GUT, 1985, 26 (05) : A564 - A565
[34] BRAF-V600E and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer
Kasi, Pashtoon Murtaza
Kamatham, Saivaishnavi
Shahjehan, Faisal
Li, Zhuo
Johnson, Patrick W.
Merchea, Amit
Colibaseanu, Dorin T.
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (02) : 236 - 241
[35] THE PROGNOSTIC VALUE OF PREOPERATIVE SERUM LEVELS OF CA-19-9 AND CEA IN PATIENTS WITH PANCREATIC-CANCER
LUNDIN, J
ROBERTS, PJ
KUUSELA, P
HAGLUND, C
BRITISH JOURNAL OF CANCER, 1994, 69 (03) : 515 - 519
[36] SERUM CEA AND CA-19-9 - POTENTIAL FUTURE DIAGNOSTIC OR SCREENING-TESTS FOR GALLBLADDER CANCER
STROM, BL
MAISLIN, G
WEST, SL
ATKINSON, B
HERLYN, M
SAUL, S
RODRIGUEZMARTINEZ, HA
RIOSDALENZ, J
ILIOPOULOS, D
SOLOWAY, RD
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (05) : 821 - 824
[37] Role of CA-19-9 in Treatment of Pancreatic Cancer: Do We Have Better Marker Than CA-19-9?
Kim, Y. J.
Yang, K. Y.
Seo, J. K.
Park, J. K.
Ryu, J. K.
Kim, Y. -T.
Yoon, Y. B.
Lee, S. H.
Hwang, J. H.
Jeong, J. B.
Jang, J. -Y.
Kim, S. -W.
PANCREAS, 2009, 38 (08) : 1016 - 1016
[38] Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Lakemeyer, Leilani
Sander, Silvia
Wittau, Mathias
Henne-Bruns, Doris
Kornmann, Marko
Lemke, Johannes
DISEASES, 2021, 9 (01)
[39] Role of Tumour Markers CEA and CA19-9 in Colorectal Cancer
Sreedhar, Rashmi
Jajoo, Suhas
Yeola, Meenakshi
Lamture, Yashwant
Tote, Darshana
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (46): : 3483 - 3488
[40] Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait
Behbehani, AI
Al-Sayer, H
Farghaly, M
Kanawati, N
Mathew, A
Al-Bader, A
Van Dalen, A
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (01): : 51 - 55

← 1 2 3 4 5 →